EPFL tuberculosis non-profit foundation iM4TB receives major grant

Posted on by in PBTZ169 | Leave a comment

EPFL spin-off “Innovative Medicines for Tuberculosis” (iM4TB) has been awarded nearly USD 750,000 by the Bill & Melinda Gates Foundation to develop a breakthrough drug against tuberculosis.

Read more here

Comments are closed.